Cargando…

Streptococcus pneumoniae Serotype 12F-CC4846 and Invasive Pneumococcal Disease after Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Japan, 2015–2017

To prevent invasive pneumococcal disease (IPD), pneumococcal conjugate vaccines (PCVs) have been implemented in many countries; however, many cases of IPD still occur and can be attributable to nonvaccine serotypes of Streptococcus pneumoniae. In Japan, the number of IPD cases attributable to seroty...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakano, Satoshi, Fujisawa, Takao, Ito, Yutaka, Chang, Bin, Matsumura, Yasufumi, Yamamoto, Masaki, Suga, Shigeru, Ohnishi, Makoto, Nagao, Miki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588537/
https://www.ncbi.nlm.nih.gov/pubmed/33079039
http://dx.doi.org/10.3201/eid2611.200087
_version_ 1783600391935492096
author Nakano, Satoshi
Fujisawa, Takao
Ito, Yutaka
Chang, Bin
Matsumura, Yasufumi
Yamamoto, Masaki
Suga, Shigeru
Ohnishi, Makoto
Nagao, Miki
author_facet Nakano, Satoshi
Fujisawa, Takao
Ito, Yutaka
Chang, Bin
Matsumura, Yasufumi
Yamamoto, Masaki
Suga, Shigeru
Ohnishi, Makoto
Nagao, Miki
author_sort Nakano, Satoshi
collection PubMed
description To prevent invasive pneumococcal disease (IPD), pneumococcal conjugate vaccines (PCVs) have been implemented in many countries; however, many cases of IPD still occur and can be attributable to nonvaccine serotypes of Streptococcus pneumoniae. In Japan, the number of IPD cases attributable to serotype 12F increased from 4.4% in 2015 to 24.6% in 2017 after 13-valent PCV was introduced. To clarify the associated genetic characteristics, we conducted whole-genome sequencing of 75 serotype 12F isolates. We identified 2 sequence types (STs) among the isolates: ST4846, which was the major type, and ST6945. Bayesian analysis suggested that these types diverged in »1942. Among serotype 12F-ST4846, we identified a major cluster, PC-JP12F, whose time of most recent common ancestor was estimated to be »2012. A phylogeographic analysis demonstrated that PC-JP12F isolates spread from the Kanto region, the most populated region in Japan, to other local regions.
format Online
Article
Text
id pubmed-7588537
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-75885372020-11-01 Streptococcus pneumoniae Serotype 12F-CC4846 and Invasive Pneumococcal Disease after Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Japan, 2015–2017 Nakano, Satoshi Fujisawa, Takao Ito, Yutaka Chang, Bin Matsumura, Yasufumi Yamamoto, Masaki Suga, Shigeru Ohnishi, Makoto Nagao, Miki Emerg Infect Dis Research To prevent invasive pneumococcal disease (IPD), pneumococcal conjugate vaccines (PCVs) have been implemented in many countries; however, many cases of IPD still occur and can be attributable to nonvaccine serotypes of Streptococcus pneumoniae. In Japan, the number of IPD cases attributable to serotype 12F increased from 4.4% in 2015 to 24.6% in 2017 after 13-valent PCV was introduced. To clarify the associated genetic characteristics, we conducted whole-genome sequencing of 75 serotype 12F isolates. We identified 2 sequence types (STs) among the isolates: ST4846, which was the major type, and ST6945. Bayesian analysis suggested that these types diverged in »1942. Among serotype 12F-ST4846, we identified a major cluster, PC-JP12F, whose time of most recent common ancestor was estimated to be »2012. A phylogeographic analysis demonstrated that PC-JP12F isolates spread from the Kanto region, the most populated region in Japan, to other local regions. Centers for Disease Control and Prevention 2020-11 /pmc/articles/PMC7588537/ /pubmed/33079039 http://dx.doi.org/10.3201/eid2611.200087 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research
Nakano, Satoshi
Fujisawa, Takao
Ito, Yutaka
Chang, Bin
Matsumura, Yasufumi
Yamamoto, Masaki
Suga, Shigeru
Ohnishi, Makoto
Nagao, Miki
Streptococcus pneumoniae Serotype 12F-CC4846 and Invasive Pneumococcal Disease after Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Japan, 2015–2017
title Streptococcus pneumoniae Serotype 12F-CC4846 and Invasive Pneumococcal Disease after Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Japan, 2015–2017
title_full Streptococcus pneumoniae Serotype 12F-CC4846 and Invasive Pneumococcal Disease after Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Japan, 2015–2017
title_fullStr Streptococcus pneumoniae Serotype 12F-CC4846 and Invasive Pneumococcal Disease after Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Japan, 2015–2017
title_full_unstemmed Streptococcus pneumoniae Serotype 12F-CC4846 and Invasive Pneumococcal Disease after Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Japan, 2015–2017
title_short Streptococcus pneumoniae Serotype 12F-CC4846 and Invasive Pneumococcal Disease after Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Japan, 2015–2017
title_sort streptococcus pneumoniae serotype 12f-cc4846 and invasive pneumococcal disease after introduction of 13-valent pneumococcal conjugate vaccine, japan, 2015–2017
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588537/
https://www.ncbi.nlm.nih.gov/pubmed/33079039
http://dx.doi.org/10.3201/eid2611.200087
work_keys_str_mv AT nakanosatoshi streptococcuspneumoniaeserotype12fcc4846andinvasivepneumococcaldiseaseafterintroductionof13valentpneumococcalconjugatevaccinejapan20152017
AT fujisawatakao streptococcuspneumoniaeserotype12fcc4846andinvasivepneumococcaldiseaseafterintroductionof13valentpneumococcalconjugatevaccinejapan20152017
AT itoyutaka streptococcuspneumoniaeserotype12fcc4846andinvasivepneumococcaldiseaseafterintroductionof13valentpneumococcalconjugatevaccinejapan20152017
AT changbin streptococcuspneumoniaeserotype12fcc4846andinvasivepneumococcaldiseaseafterintroductionof13valentpneumococcalconjugatevaccinejapan20152017
AT matsumurayasufumi streptococcuspneumoniaeserotype12fcc4846andinvasivepneumococcaldiseaseafterintroductionof13valentpneumococcalconjugatevaccinejapan20152017
AT yamamotomasaki streptococcuspneumoniaeserotype12fcc4846andinvasivepneumococcaldiseaseafterintroductionof13valentpneumococcalconjugatevaccinejapan20152017
AT sugashigeru streptococcuspneumoniaeserotype12fcc4846andinvasivepneumococcaldiseaseafterintroductionof13valentpneumococcalconjugatevaccinejapan20152017
AT ohnishimakoto streptococcuspneumoniaeserotype12fcc4846andinvasivepneumococcaldiseaseafterintroductionof13valentpneumococcalconjugatevaccinejapan20152017
AT nagaomiki streptococcuspneumoniaeserotype12fcc4846andinvasivepneumococcaldiseaseafterintroductionof13valentpneumococcalconjugatevaccinejapan20152017